Maintenance Treatment with Guadecitabine (SGI-110) in High Risk MDS and AML Patients after Allogeneic Stem Cell Transplantation

被引：1
|
作者：
Oran, Betul
Alatrash, Gheath
Alousi, Amin M.
Mehta, Rohtesh S.
Hosing, Chitra
Popat, Uday R.
Im, Jin S.
McCarty, Jessica M.
Ramos, Jennifer D.
Keer, Harold N.
Thall, Peter F.
Champlin, Richard E.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-134272
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] TREC after allogeneic stem cell transplantation as a predictive marker for relapse after AML and MDS/MPS
    Uzunel, M.
    Sairafi, D.
    Mattsson, J.
    Uhlin, M.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S133 - S133
  • [22] Clostridium Difficile infections in patients with AML or MDS undergoing allogeneic hematopoietic stem cell transplantation identify high risk for adverse outcome
    Amberge, Simon
    Kramer, Michael
    Schroettner, Percy
    Heidrich, Katharina
    Schmelz, Renate
    Middeke, Jan M.
    Gunzer, Florian
    Hampe, Jochen
    Schetelig, Johannes
    Bornhaeuser, Martin
    Stoelzel, Friedrich
    BONE MARROW TRANSPLANTATION, 2020, 55 (02) : 367 - 375
  • [23] 5-azacitidine in combination with donor lymphocyte infusions for the treatment of patients with MDS or AML relapsing after allogeneic stem cell transplantation
    Czibere, A.
    Graef, T.
    Bruns, I.
    Zohren, F.
    Germing, U.
    Haas, R.
    Kobbe, G.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S64 - S64
  • [24] Clostridium Difficile infections in patients with AML or MDS undergoing allogeneic hematopoietic stem cell transplantation identify high risk for adverse outcome
    Simon Amberge
    Michael Kramer
    Percy Schröttner
    Katharina Heidrich
    Renate Schmelz
    Jan M. Middeke
    Florian Gunzer
    Jochen Hampe
    Johannes Schetelig
    Martin Bornhäuser
    Friedrich Stölzel
    Bone Marrow Transplantation, 2020, 55 : 367 - 375
  • [25] Glasdegib as maintenance therapy for patients with AML and MDS patients at high risk for postallogeneic stem cell transplant relapse
    Kent, Andrew
    Vasu, Sumithira
    Schatz, Derek
    Monson, Natalie
    Devine, Steven
    Smith, Clayton
    Gutman, Jonathan A.
    Pollyea, Daniel A.
    BLOOD ADVANCES, 2020, 4 (13) : 3102 - 3108
  • [26] Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)
    Bug, G.
    Burchert, A.
    Wagner, E-M
    Kroeger, N.
    Berg, T.
    Gueller, S.
    Metzelder, S. K.
    Wolf, A.
    Huenecke, S.
    Bader, P.
    Schetelig, J.
    Serve, H.
    Ottmann, O. G.
    LEUKEMIA, 2017, 31 (11) : 2523 - 2525
  • [27] Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)
    G Bug
    A Burchert
    E-M Wagner
    N Kröger
    T Berg
    S Güller
    S K Metzelder
    A Wolf
    S Hünecke
    P Bader
    J Schetelig
    H Serve
    O G Ottmann
    Leukemia, 2017, 31 : 2523 - 2525
  • [28] HIGH TOLERABILITY OF PROLONGED AZACITIDINE MAINTENANCE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH AML LACKING A TARGETABLE MUTATION
    Do, Cuong An
    Mamez, Anne-Claire
    Pradier, Amandine
    Morin, Sarah
    Bernardi, Chiara
    Prati-Perdikis, Sarah
    Beauverd, Yan
    Longval, Thomas
    Mappoura, Maria
    Noetzlin, Sarah
    Dubouchet, Laetitia
    Laspa, Evgenia
    Maulini, Marie
    Tran, Thien-An
    Ortiz, Carmen de Ramon
    Masouridi-Levrat, Stavroula
    Simonetta, Federico
    Chalandon, Yves
    Giannotti, Federica
    BONE MARROW TRANSPLANTATION, 2024, 59 : 163 - 164
  • [29] Fludarabine/melphalan conditioning for allogeneic stem cell transplantation (SCT) in elderly patients with AML/MDS
    Kennedy, GA
    Butler, J
    Durrant, S
    Hill, GR
    Western, R
    Morton, J
    BLOOD, 2005, 106 (11) : 438B - 439B
  • [30] Safety and tolerability of guadecitabine (SGI-110) plus cisplatin in patients with platinum refractory germ cell tumors (GCT): A phase 1 study
    Albany, Costantine
    Hashemi, Neda S.
    Fang, Fang
    Lowder, James
    Einhorn, Lawrence
    Nephew, Kenneth
    CANCER RESEARCH, 2018, 78 (13)
12345